Sushil Patel
Chief Executive Officer at REPLIMUNE GROUP, INC.
Net worth: 2 M $ as of 31/03/2024
Profile
Sushil Patel is currently the Chief Executive Officer & Director at Replimune Group, Inc. since 2024 and an Independent Director at Revolution Medicines, Inc. since 2022.
Previously, he worked at Genentech, Inc. from 2002 to 2021, where he held the position of Vice President-Franchise & Head-Oncology from 2008 to 2021.
Dr. Patel completed his graduate degree at Imperial College London in 1993, obtained a doctorate degree from the University of London in 1999, and received his undergraduate degree from the University of Warwick in 1992.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0.38% | 01/04/2024 | 232,208 ( 0.38% ) | 2 M $ | 31/03/2024 |
| 10/04/2024 | 15,700 ( 0.01% ) | 506 011 $ | 31/03/2024 |
Sushil Patel active positions
| Companies | Position | Start |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 01/04/2024 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 16/06/2022 |
Former positions of Sushil Patel
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2021 |
Training of Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Sushil Patel
